TLR4 and metabolic dysfunction-associated steatotic liver disease: GM-induced dysbiosis enhances the hepatic TLR4 expression and pro-inflammatory cytokine levels in NAFLD and NASH patients by disrupting the intestine’s inner lining and prompting the lipopolysaccharide (LPS) translocation in TLR4 signaling activation [7].